9.21
1.66%
+0.15
Handel nachbörslich:
9.20
-0.01
-0.11%
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
Chart of the Day: ADMA Biologics - Hitting New Highs - The Globe and Mail
The Globe and Mail
Chart of the Day: ADMA Biologics - Hitting New Highs - The Globe and Mail
The Globe and Mail
July 19th Options Now Available For ADMA Biologics - Nasdaq
Nasdaq
Short Interest in ADMA Biologics, Inc. (NASDAQ:ADMA) Grows By 7.5% - MarketBeat
MarketBeat
ADMA Biologics (ADMA) to Report Q2 Earnings: What's in Store? - Yahoo New Zealand News
Yahoo New Zealand News
ADMA Biologics (ADMA) to Report Q2 Earnings: What's in Store? - Yahoo New Zealand News
Yahoo New Zealand News
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Acquired by New York State Common Retirement Fund - Defense World
Defense World
Trend Tracker for (ADMA) - Stock Traders Daily
Stock Traders Daily
Zacks.com featured highlights ADMA Biologics, Northern Technologies, PlayAGS, Merchants Bank and Strategic ... - Yahoo Finance
Yahoo Finance
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Up 7.5% in April - Defense World
Defense World
Adma Biologics (ADMA) Gains As Market Dips: What You Should Know - Yahoo Lifestyle Australia
Yahoo Lifestyle Australia
ADMA Biologics (NASDAQ:ADMA) Hits New 52-Week High at $9.33 - MarketBeat
MarketBeat
5 Stocks With Recent Price Strength to Tap May's Rally
Zacks Investment Research
Should You Worry About ADMA Biologics, Inc.'s (NASDAQ:ADMA) CEO Salary Level? - Yahoo Movies UK
Yahoo Movies UK
Russell Investments Group Ltd. Purchases 236,255 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
MarketBeat
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Zacks Investment Research
Zacks Investment Research
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Canada Finance
Yahoo Canada Finance
ADMA Biologics hits 52-week high on Q1 beat, guidance raise - MSN
MSN
ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next - Simply Wall St
Simply Wall St
ADMA Biologics (ADMA) to Report Q2 Earnings: What's in Store? - Yahoo New Zealand News
Yahoo New Zealand News
What Kind Of Investor Owns Most Of ADMA Biologics, Inc. (NASDAQ:ADMA)? - Yahoo Canada Shine On
Yahoo Canada Shine On
Giving ADMA Biologics A Well-Deserved 'Booyah' (NASDAQ:ADMA) - Seeking Alpha
Seeking Alpha
Mizuho Raises ADMA Biologics (NASDAQ:ADMA) Price Target to $12.00 - Defense World
Defense World
ADMA Biologics (NASDAQ:ADMA) Given New $10.00 Price Target at HC Wainwright - Defense World
Defense World
ADMA Biologics First Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Yahoo Finance
ADMA Biologics First Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Yahoo Finance
Earnings call: ADMA Biologics surpasses forecasts with robust Q1 results - Investing.com South Africa
Investing.com South Africa
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
HC Wainwright Adjusts ADMA Biologics' Price Target to $10 From $7.50, Maintains Buy Rating - Marketscreener.com
Marketscreener.com
Raymond James Boosts ADMA Biologics (NASDAQ:ADMA) Price Target to $10.00 - MarketBeat
MarketBeat
ADMA Biologics (NASDAQ:ADMA) Shares Gap Up After Earnings Beat - MarketBeat
MarketBeat
ADMA Biologics stock gains on Q1 beat (NASDAQ:ADMA) - Seeking Alpha
Seeking Alpha
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
ADMA Biologics Inc (ADMA) Surpasses Analyst Revenue and Earnings Forecasts in Q1 2024 - Yahoo Finance
Yahoo Finance
Earnings call: ADMA Biologics surpasses forecasts with robust Q1 results - Investing.com Canada
Investing.com Canada
Earnings call: ADMA Biologics surpasses forecasts with robust Q1 results - Investing.com India
Investing.com India
ADMA Biologics Shares Rise 23% After 1Q Earnings Beat Estimates - MarketWatch
MarketWatch
ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results - ADMA Biologics (NASDAQ:ADMA) - Benzinga
Benzinga
ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results - ADMA Biologics (NASDAQ:ADMA) - Benzinga
Benzinga
Adma Biologics: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates - Zacks Investment Research
Zacks Investment Research
ADMA Biologics Inc earnings beat by $0.05, revenue topped estimates - Investing.com South Africa
Investing.com South Africa
ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q1 2024 - MSN
MSN
ADMA Biologics (NASDAQ:ADMA) Hits New 1-Year High at $6.97 - MarketBeat
MarketBeat
ADMA Biologics Inc earnings beat by $0.05, revenue topped estimates - Investing.com India
Investing.com India
Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Canada Finance
Yahoo Canada Finance
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Adma Biologics: Q1 Earnings Snapshot - Press of Atlantic City
Press of Atlantic City
Kapitalisierung:
|
Volumen (24h):